Chromatographically isolated CD63+CD81+ extracellular vesicles from mesenchymal stromal cells rescue cognitive impairments after TBI

Proceedings of the National Academy of Sciences of the United States of America

Volumn 113, Issue 1, 2016, Pages 170-175

  Kim, Dong Ki ^a   Nishida, Hidetaka ^a   An, Su Yeon ^a   Shetty, Ashok K ^a   Bartosh, Thomas J ^a   Prockop, Darwin J ^a  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

Efficacy assay; Exosomes; MSCs; Neuroinflammation

Indexed keywords

CD63 ANTIGEN; CD81 ANTIGEN; BIOLOGICAL MARKER; SERUM-FREE MEDIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASSAY; CHROMATOGRAPHY; COGNITIVE DEFECT; EXOSOME; HUMAN; HUMAN CELL; MESENCHYMAL STROMA CELL; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; TRAUMATIC BRAIN INJURY; ANIMAL; BRAIN INJURY; CELL CULTURE; CHEMISTRY; COGNITION DISORDERS; COMPLICATION; ENCEPHALITIS; ION EXCHANGE CHROMATOGRAPHY; PSYCHOLOGY; SERUM-FREE MEDIUM; SPATIAL LEARNING; ULTRASTRUCTURE;

ANIMALS; ANTIGENS, CD63; ANTIGENS, CD81; BIOMARKERS; BRAIN INJURIES; CELLS, CULTURED; CHROMATOGRAPHY, ION EXCHANGE; COGNITION DISORDERS; CULTURE MEDIA, SERUM-FREE; ENCEPHALITIS; EXTRACELLULAR VESICLES; HUMANS; MESENCHYMAL STROMAL CELLS; MICE; SPATIAL LEARNING;

EID: 84953295050     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1522297113     Document Type: Article

References (50)

1. Maas AI, Stocchetti N, Bullock R (2008) Moderate and severe traumatic brain injury in adults. Lancet Neurol 7(8):728-741.
2. Heneka MT, Kummer MP, Latz E (2014) Innate immune activation in neurodegenerative disease. Nat Rev Immunol 14(7):463-477.
3. Lozano D, et al. (2015) Neuroinflammatory responses to traumatic brain injury: Etiology, clinical consequences, and therapeutic opportunities. Neuropsychiatr Dis Treat 11:97-106.
4. Reis C, et al. (2015) What's new in traumatic brain injury: Update on tracking, monitoring and treatment. Int J Mol Sci 16(6):11903-11965.
5. Loane DJ, Stoica BA, Faden AI (2015) Neuroprotection for traumatic brain injury. Handb Clin Neurol 127:343-366.
6. Prockop DJ, Kota DJ, Bazhanov N, Reger RL (2010) Evolving paradigms for repair of tissues by adult stem/progenitor cells (MSCs). J Cell Mol Med 14(9):2190-2199.
7. Keating A (2012) Mesenchymal stromal cells: New directions. Cell Stem Cell 10(6): 709-716.
8. Kramann R, et al. (2015) Perivascular Gli1+ progenitors are key contributors to injuryinduced organ fibrosis. Cell Stem Cell 16(1):51-66.
9. Schwarz EJ, Alexander GM, Prockop DJ, Azizi SA (1999) Multipotential marrow stromal cells transduced to produce L-DOPA: Engraftment in a rat model of Parkinson disease. Hum Gene Ther 10(15):2539-2549.
10. Hofstetter CP, et al. (2002) Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci USA 99(4):2199-2204.
11. Ohtaki H, et al. (2008) Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses. Proc Natl Acad Sci USA 105(38):14638-14643.
12. Qu C, et al. (2008) Treatment of traumatic brain injury in mice with marrow stromal cells. Brain Res 1208:234-239.
13. Lim PK, Patel SA, Gregory LA, Rameshwar P (2010) Neurogenesis: Role for microRNAs and mesenchymal stem cells in pathological states. Curr Med Chem 17(20):2159-2167.
14. Joyce N, et al. (2010) Mesenchymal stem cells for the treatment of neurodegenerative disease. Regen Med 5(6):933-946.
15. Uccelli A, Benvenuto F, Laroni A, Giunti D (2011) Neuroprotective features of mesenchymal stem cells. Best Pract Res Clin Haematol 24(1):59-64.
16. Kocsis JD, Honmou O (2012) Bone marrow stem cells in experimental stroke. Prog Brain Res 201:79-98.
17. Forostyak S, Jendelova P, Sykova E (2013) The role of mesenchymal stromal cells in spinal cord injury, regenerative medicine and possible clinical applications. Biochimie 95(12):2257-2270.
18. Zhang R, et al. (2013) Anti-inflammatory and immunomodulatory mechanisms of mesenchymal stem cell transplantation in experimental traumatic brain injury. J Neuroinflammation 10:106.
19. Peng W, et al. (2015) Systematic review and meta-analysis of efficacy of mesenchymal stem cells on locomotor recovery in animal models of traumatic brain injury. Stem Cell Res Ther 6:47.
20. Prockop DJ, Oh JY (2012) Mesenchymal stem/stromal cells (MSCs): Role as guardians of inflammation. Mol Ther 20(1):14-20.
21. Lee RH, et al. (2009) Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 5(1):54-63.
22. Oh JY, et al. (2010) Anti-inflammatory protein TSG-6 reduces inflammatory damage to the cornea following chemical and mechanical injury. Proc Natl Acad Sci USA 107(39):16875-16880.
23. Choi H, Lee RH, Bazhanov N, Oh JY, Prockop DJ (2011) Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-κB signaling in resident macrophages. Blood 118(2):330-338.
24. Oh JY, et al. (2012) Intravenous mesenchymal stem cells prevented rejection of allogeneic corneal transplants by aborting the early inflammatory response. Mol Ther 20(11):2143-2152.
25. Gibb SL, et al. (2015) TIMP3 attenuates the loss of neural stem cells, mature neurons and neurocognitive dysfunction in traumatic brain injury. Stem Cells 33(12): 3530-3544.
26. Yáñez-Mó M, et al. (2015) Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles 4:27066.
27. Lo Cicero A, Stahl PD, Raposo G (2015) Extracellular vesicles shuffling intercellular messages: For good or for bad. Curr Opin Cell Biol 35:69-77.
28. Heldring N, Mäger I, Wood MJ, Le Blanc K, Andaloussi SE (2015) Therapeutic potential of multipotent mesenchymal stromal cells and their extracellular vesicles. Hum Gene Ther 26(8):506-517.
29. György B, Hung ME, Breakefield XO, Leonard JN (2015) Therapeutic applications of extracellular vesicles: Clinical promise and open questions. Annu Rev Pharmacol Toxicol 55:439-464.
30. Zhang Y, et al. (2015) Effect of exosomes derived from multipluripotent mesenchymal stromal cells on functional recovery and neurovascular plasticity in rats after traumatic brain injury. J Neurosurg 122(4):856-867.
31. Phinney DG, et al. (1999) Donor variation in the growth properties and osteogenic potential of human marrow stromal cells. J Cell Biochem 75(3):424-436.
32. Montzka K, et al. (2009) Neural differentiation potential of human bonemarrow-derived mesenchymal stromal cells: Misleading marker gene expression. BMC Neurosci 10:16.
33. Siddappa R, Licht R, van Blitterswijk C, de Boer J (2007) Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering. J Orthop Res 25(8):1029-1041.
34. Lee RH, et al. (2014) TSG-6 as a biomarker to predict efficacy of human mesenchymal stem/progenitor cells (hMSCs) in modulating sterile inflammation in vivo. Proc Natl Acad Sci USA 111(47):16766-16771.
35. Oksvold MP, Neurauter A, Pedersen KW (2015) Magnetic bead-based isolation of exosomes. Methods Mol Biol 1218:465-481.
36. Pati S, et al. (2011) Human mesenchymal stem cells inhibit vascular permeability by modulating vascular endothelial cadherin/β-catenin signaling. Stem Cells Dev 20(1): 89-101.
37. Leutgeb S, Leutgeb JK (2007) Pattern separation, pattern completion, and new neuronal codes within a continuous CA3 map. Learn Mem 14(11):745-757.
38. Yassa MA, Stark CE (2011) Pattern separation in the hippocampus. Trends Neurosci 34(10):515-525.
39. Sekiya I, et al. (2002) Expansion of human adult stem cells from bone marrow stroma: Conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells 20(6):530-541.
40. Prockop DJ, Keating A (2012) Relearning the lessons of genomic stability of human cells during expansion in culture: Implications for clinical research. Stem Cells 30(6): 1051-1052.
41. Boregowda SV, et al. (2012) Atmospheric oxygen inhibits growth and differentiation of marrow-derived mouse mesenchymal stem cells via a p53-dependent mechanism: implications for long-term culture expansion. Stem Cells 30(5):975-987.
42. Sharma RR, Pollock K, Hubel A, McKenna D (2014) Mesenchymal stem or stromal cells: A review of clinical applications and manufacturing practices. Transfusion 54(5): 1418-1437.
43. Liu KD, et al. (2014) Design and implementation of the START (STem cells for ARDS Treatment) trial, a phase 1/2 trial of human mesenchymal stem/stromal cells for the treatment of moderate-severe acute respiratory distress syndrome. Ann Intensive Care 4:22.
44. Sekiya I, Muneta T, Horie M, Koga H (2015) Arthroscopic transplantation of synovial stem cells improves clinical outcomes in knees with cartilage defects. Clin Orthop Relat Res 473(7):2316-2326.
45. Spees JL, Olson SD, Whitney MJ, Prockop DJ (2006) Mitochondrial transfer between cells can rescue aerobic respiration. Proc Natl Acad Sci USA 103(5):1283-1288.
46. Islam MN, et al. (2012) Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. Nat Med 18(5):759-765.
47. Pochampally RR, Smith JR, Ylostalo J, Prockop DJ (2004) Serum deprivation of human marrow stromal cells (hMSCs) selects for a subpopulation of early progenitor cells with enhanced expression of OCT-4 and other embryonic genes. Blood 103(5): 1647-1652.
48. Vallabhaneni KC, et al. (2015) Extracellular vesicles from bone marrow mesenchymal stem/stromal cells transport tumor regulatory microRNA, proteins, and metabolites. Oncotarget 6(7):4953-4967.
49. Phinney DG, et al. (2015) Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs. Nat Commun 6:8472.
50. Cuiffo BG, et al. (2014) MSC-regulated microRNAs converge on the transcription factor FOXP2 and promote breast cancer metastasis. Cell Stem Cell 15(6):762-774.